Myrexis Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing novel small molecule drugs for the treatment of cancer. Myriad's pipeline includes clinical and pre-clinical product candidates with distinct mechanisms of action and novel chemical structures.
305 Chipeta Way
Salt Lake City, UT 84108